BridGene Biosciences
Business Services · California, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
75 Nicholson Ln, San Jose, California, 9...Phone Number
(408) 498-8127Website
www.bridgenebio.comRevenue
$8.5 MillionIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1
About BridGene Biosciences
BridGene Biosciences is a biotechnology company pioneering the discovery and development of innovative small-molecule drugs that target traditionally undruggable targets. Leveraging its proprietary IMTAC (Isobaric Mass-Tagged Affinity Characterization) chemoproteomic platform, BridGene screens covalent small molecules against the entire proteome in live cells to identify novel binding sites and drug candidates for high-value targets.Explore more
BridGene Biosciences Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is BridGene Biosciences your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
BridGene Biosciences, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on BridGene Biosciences recently announced quarterly report
Check out if BridGene Biosciences is spiking on competitors!
Click to see if BridGene Biosciences had a recent Job posting/layoffs
Funding: Get notified immidiatlly once BridGene Biosciences has new funding data
Congratulate Masked Content for being promoted to Masked Content at BridGene Biosciences
Product Launch: Get notified when BridGene Biosciences launches new products
Website visits: Recent activity has been detected on your website
Check if BridGene Biosciences has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Find VP level buyers at BridGene Biosciences
Find 2 more new buyers
Compare Similar Companies to BridGene Biosciences
Compare insights from companies similar to BridGene Biosciences, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
BridGene Biosciences is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
BridGene Biosciences is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about BridGene Biosciences.
BridGene Biosciences financials insights
Gather financial insights about BridGene Biosciences, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2021
Series A
$12M
2025
Series B
$66.5M
BridGene Biosciences Tech Stack
A closer look at the technologies used by BridGene Biosciences
Most Recent Scoops
Funding
Funding
Funding
Funding
Funding
BridGene Biosciences News & Media
BridGene Biosciences Appoints Nobel Laureate Bruce A. Beutler, M.D., to Scientific Advisory Board
Pioneering immunologist and genetics leader to advise on advancement of novel small-molecule therapeutics for hard-to-drug targets SAN JOSE, Calif., Jan. 5, 2026 /PRNewswire/ -- BridGene Biosciences, Inc., a leader in the discovery of small-molecule drugs for traditionally "hard-to-drug"...BridGene Biosciences Inks $28M Series B+
SAN JOSE, CA, BridGene Biosciences today announced the recent completion of a $28 million Series B+ financing round.BridGene Biosciences Raises $28 Million in Series B+ Financing to Accelerate Clinical ...
Funding led by Bayland Capital , with participation from GTJA Investment Group , Proxima Ventures , Lapam Capital , and Grains Valley Venture...BridGene Biosciences to Present Three Novel Covalent Inhibitors at the 36th EORTC-NCI-AACR Symposium
Presentations on cMyc, ADAR1, and PAX8 inhibitors to be held on October 25, 2024 SAN JOSE, Calif., Oct. 9, 2024 /PRNewswire/ -- BridGene Biosciences, a leader in the discovery of small molecule drugs for traditionally "hard-to-drug" targets, today announced it will present three...
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Frequently Asked Questions Regarding BridGene Biosciences
Sign Up For FreeTo access detailed company insights
BridGene Biosciences is a biotechnology company pioneering the discovery and development of innovative small-molecule drugs that target traditionally undruggable targets. Leveraging its proprietary IMTAC (Isobaric Mass-Tagged Affinity Characterization) chemoproteomic platform, BridGene screens covalent small molecules against the entire proteome in... Read More
